Altair Nanotechnologies Inc. (NASDAQ: ALTI) announced today that it will host a project update conference call
Altair Nanotechnologies Inc. (NASDAQ: ALTI), RBC Dain Rauscher issued a downgrade of the common stock price pertaining to a company covered by its research group
Altair Nanotechnologies Inc. (NASDAQ: ALTI), announced that its CEO and President, Alan J. Gotcher, Ph.D., is presenting today at ThinkEquity Partners 3rd Annual Growth Conference.
Company Receives Research Grant of $476,850 to Continue Development on Nano-Structured Electrodes for Next Generation Batteries and Super Capacitors
APPLEXION of France, the University of Western Sydney (UWS), Food Science Australia and Dairy Australia have joined forces to market a Franco-Australian eco-friendly dairy-processing breakthrough, which can separate the nutrients contained in whey and turn them into valuable food and pharmaceutical-grade supplements for use in medicines, healthcare and food products.
Imex Promotion of France has launched its Moon Clock® – a medal winner for its features and originality at the 2004 Paris Lépine Awards for Innovation. The clock turns at the speed of the lunar month, i.e. over 29 ½ days. It shows the time elapsing between two new or full moons. It is unique on the market, and shows at a glance the phases of the moon as well as the changes in its appearance on a day-to-day basis. With the Moon Clock ®, it is no longer necessary to rely on observations of the sky as users know precisely when the next full or new moon will be.
Florida Author - Michael Levy has written an astounding article on the Kabbalah - that will reveal the ancient secrets to any person who is curious about their views on the meaning of life.
Global publisher John Wiley & Sons, Inc., today announced the launch of the Analytical Sciences Backfile Collection, the latest addition to its growing collection of digitized journal libraries, and the second to be launched in this year. The Analytical Sciences Backfile Collection is available via Wiley InterScience (http://www.interscience.wiley.com/backfiles), Wiley’s dynamic online publishing platform.
There is no stopping the global life sciences industry. With worldwide sales of drugs crossing $500 billon, manufacturers are increasingly spending on research & development (R&D), and implementing successful strategies to acquire a greater share of this expanding industry. “New drug discovery”, “biopharmaceutical research”, “custom synthesis”, and “strategic outsourcing” are the latest industry buzzwords. In such a competitive scenario, the Indian pharmaceutical market has shown rapid growth over the years, and has established itself in the global arena. Indian fine chemical and drug manufacturers are establishing themselves as participants to be reckoned with.
Significant performance and cost improvement implications for applications having severe durability or corrosion-resistance requirements
Callisto Pharmaceuticals, Inc. (AMEX: KAL), a biopharmaceutical company primarily focused on the development of drugs to treat cancer and osteolytic bone disease, announced today a second clinical trial of Atiprimod, its lead drug presently in a Phase I/IIa trial in relapsed multiple myeloma patients.
Global publisher John Wiley & Sons, Inc., has announced the launch of the Cell & Developmental Biology Backfile Collection, the latest addition to its growing collection of digitized journal libraries, and the first to be launched in 2005.
The Bournemouth University-based Inforce Foundation has successfully completed one of the world's most unique training programmes which featured the construction and excavation of the world's first 'mock' mass grave.
www.NanotechnologyInvestment.com, a global research portal for the nanotechnology investment community is pleased to feature an award winning private nanotechnology coating company positioned in the environmental coatings industry.